1. Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
   Karishma R. Rajani et al, 2019, Frontiers in Oncology CrossRef
2. Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
   Janina Świderska et al, 2022, Diagnostics CrossRef
3. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis
   Anusha Thadi et al, 2018, Vaccines CrossRef
4. Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer
   Niclas C. Blessin et al, 2019, Disease Markers CrossRef
5. Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer
   Nicole E. James et al, 2021, Frontiers in Oncology CrossRef
6. Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer
   Paul Buderath et al, 2019, Frontiers in Oncology CrossRef
7. The Role of NcRNAs to Regulate Immune Checkpoints in Cancer
   Yicun Jiang et al, 2022, Frontiers in Immunology CrossRef
8. Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
   Elena García-Martínez et al, 2020, Angiogenesis CrossRef
9. Advances in the treatment of malignant ascites in China
   Junzi Zhang et al, 2024, Supportive Care in Cancer CrossRef
10. Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
    Aarushi Audhut Caro et al, 2022, Cancers CrossRef
11. Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma
    Akira Yabuno et al, 2020, Scientific Reports CrossRef
12. The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma
    Simona Miceska et al, 2023, Radiology and Oncology CrossRef
13. Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer
    Iwona Wertel et al, 2020, Journal of Immunology Research CrossRef
14. The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies
    Oliviero Marinelli et al, 2019, Frontiers in Oncology CrossRef
15. BTLA biology in cancer: from bench discoveries to clinical potentials
    Anna Andrzejczak et al, 2024, Biomarker Research CrossRef
16. The Perfect Combination: Enhancing Patient Response to PD-1-Based Therapies in Epithelial Ovarian Cancer
    Nicole E. James et al, 2020, Cancers CrossRef
17. The correlation of PD-L1 expression in cytological and histological material of serous high-grade ovarian cancer
    Ljubiša Jovanović et al, 2023, Srpski medicinski casopis Lekarske komore CrossRef
18. Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer
    Yue Fan et al, 2020, Computational and Mathematical Methods in Medicine CrossRef